Lars Olof Hedbys

Lars Olof Hedbys

Director/Board Member chez CHOSA ONCOLOGY AB

67 ans
Health Technology
Commercial Services
Consumer Services

Profil

Dr. Lars Olof Hedbys is an Independent Director at Xintela AB, a Partner at Ventac Partners A/S, a Partner at Ventac Partners GmbH, a Chairman at Asgard Therapeutics AB, a Chairman at Strominnate Therapeutics AB, a Chairman at Vetiqure AB, a Chief Executive Officer & Director at Vagnlyftaren AB and a Director & Partner at Ventac Partners AB.
He is on the Board of Directors at Chosa Oncology AB, Xintela AB, Vagnlyftaren AB, CanImGuide Therapeutics AB, Immodulate Pharma AB, Cell Invent AB, Cell Invent Sweden AB and Ventac Partners AB.
Dr. Hedbys was previously employed as a Chairman by Scandinavian ChemoTech AB, a Chairman by Smile Incubator AB, a Chief Executive Officer by Glycorex Transplantation AB, a Director & IR Contact by Idogen AB, a Vice President & General Manager by Astrazeneca Alpha BV, a Chairman by Iampatient AB, a Chairman by Lund Life Science Incubator, a Chief Executive Officer by Mando AB, a Chief Executive Officer by Pharmiva AB, a General Manager by Synarc A/S, and a Senior Advisor by Ventac Partners LLC.
He also served on the board at Hamlet BioPharma AB, RhoVac AB, Cartela AB and Regenesance BV.
He received his graduate degree from Chalmers University of Technology and a doctorate degree from Faculty of Engineering, Lund University.

Postes actifs de Lars Olof Hedbys

SociétésPosteDébut
XINTELA AB Director/Board Member 01/01/2021
CHOSA ONCOLOGY AB Director/Board Member 01/01/2023
Immodulate Pharma AB Director/Board Member -
Director/Board Member -
Ventac Partners AB Director/Board Member -
Vetiqure AB Chairman -
Chairman -
Cell Invent AB Director/Board Member -
Chairman -
░░░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
Tous les postes actifs de Lars Olof Hedbys

Anciens postes connus de Lars Olof Hedbys

SociétésPosteFin
░░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Lars Olof Hedbys

Formation de Lars Olof Hedbys

Chalmers University of Technology Graduate Degree
Faculty of Engineering, Lund University Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Lars Olof Hedbys

Relations

64

Relations au 1er degré

30

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées7
GLYCOREX TRANSPLANTATION AB

Health Technology

XINTELA AB

Health Technology

IDOGEN AB (PUBL)

Health Technology

HAMLET PHARMA AB (PUBL)

Health Technology

PHARMIVA AB (PUBL)

Commercial Services

SCANDINAVIAN CHEMOTECH AB

Health Technology

CHOSA ONCOLOGY AB

Commercial Services

Entreprise privées21

Health Technology

Health Services

Commercial Services

Health Technology

Synarc A/S

Astrazeneca Alpha BV

Retail Trade

Ventac Partners LLC

Commercial Services

Lund Life Science Incubator

Vagnlyftaren AB

Health Technology

Technology Services

Commercial Services

Commercial Services

Immodulate Pharma AB

Cell Invent AB

Commercial Services

Vetiqure AB

Ventac Partners AB

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Lars Olof Hedbys